Steel, D H W
Parkes, C
Papastavrou, V T
Avery, P J
El-Ghrably, I A
Habib, M S
Sandinha, M T
Smith, J
Stannard, K P
Vaideanu-Collins, D
Hillier, R J
Article History
Received: 3 August 2015
Accepted: 3 February 2016
First Online: 11 March 2016
Competing interests
: DHWS, RJH, and IAE declare that they have attended advisory boards for Alcon in connection with ocriplasmin and received travel expenses. MSH declares he has received travel expenses from Alcon to attend meetings.